Hypoxia Imaging for Esophageal Cancer to Guide Personalized Radiation Therapy

PHASE1RecruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 12, 2021

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2027

Conditions
Esophageal Cancer
Interventions
RADIATION

Radiation

Prior to the start of study therapy, eligible subjects will receive a FMISO-PET scan. If there is uptake visualized on the scan, the tumor will be considered as hypoxic. If there is no uptake seen on the FMISO-PET scan, tumors will be labeled not hypoxic. Subjects with tumors identified by imaging as hypoxic will be treated with a higher dose of radiation therapy. Tumors will be defined as being hypoxic if FMISO accumulation occurs as demonstrated by standardized uptake value (SUV) uptake in the tumor.

DRUG

FMISO PET CT

Prior to the start of study therapy, eligible subjects will receive a FMISO-PET scan. If there is uptake visualized on the scan, the tumor will be considered as hypoxic. If there is no uptake seen on the FMISO-PET scan, tumors will be labeled not hypoxic.

Trial Locations (1)

84112

RECRUITING

Huntsman Cancer Institute, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER